Cargando…
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985056/ https://www.ncbi.nlm.nih.gov/pubmed/35388182 http://dx.doi.org/10.1038/s41380-022-01545-3 |
| _version_ | 1784682291690209280 |
|---|---|
| author | Khani, Elnaz Entezari-Maleki, Taher |
| author_facet | Khani, Elnaz Entezari-Maleki, Taher |
| author_sort | Khani, Elnaz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8985056 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89850562022-04-06 Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists Khani, Elnaz Entezari-Maleki, Taher Mol Psychiatry Correspondence Nature Publishing Group UK 2022-04-06 2022 /pmc/articles/PMC8985056/ /pubmed/35388182 http://dx.doi.org/10.1038/s41380-022-01545-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Khani, Elnaz Entezari-Maleki, Taher Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title | Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title_full | Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title_fullStr | Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title_full_unstemmed | Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title_short | Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| title_sort | fluvoxamine and long covid-19; a new role for sigma-1 receptor (s1r) agonists |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985056/ https://www.ncbi.nlm.nih.gov/pubmed/35388182 http://dx.doi.org/10.1038/s41380-022-01545-3 |
| work_keys_str_mv | AT khanielnaz fluvoxamineandlongcovid19anewroleforsigma1receptors1ragonists AT entezarimalekitaher fluvoxamineandlongcovid19anewroleforsigma1receptors1ragonists |